CVX-210 vaccine

CVX-210 vaccine, currently in development as an antibody injection by CardioVax, is waiting regulatory clearance to start clinical trials. These vaccines are being developed against heart attack. They are based upon the premise that Coronary heart disease occurs when fatty plaques build up in the blood vessels feeding the heart and over time become narrowed. Parts of the plaque may break off causing a clot to form which can block the artery causing a heart attack. The scientists have shown that it is possible to alter the way immune system reacts to plaques in the arteries to reduce inflammation and the severity of the build-up. In fact, the scientists say that injections of antibodies could help prevent the build up of fat in the arteries which cause narrowing’s and break off leading to heart attacks.